TNYA
Tenaya Therapeutics Inc
NASDAQ: TNYA · HEALTHCARE · BIOTECHNOLOGY
$0.69
+4.66% today
Updated 2026-04-30
Market cap
$145.87M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.59
Dividend yield
—
52W range
$0 – $2
Volume
4.3M
Tenaya Therapeutics Inc (TNYA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-24.10M | $-35.45M | $-60.81M | $-104.42M | $-102.07M | $-90.50M | $-68.26M |
| Capital expenditures | $2.93M | $9.76M | $25.12M | $20.63M | $1.24M | $1.02M | $618000.00 |
| Depreciation | $1.99M | $2.48M | $2.96M | $6.47M | $8.69M | $8.47M | — |
| Stock-based comp | $414000.00 | $741000.00 | $2.95M | $11.47M | $15.31M | $16.50M | $13.05M |
| Free cash flow | $-27.02M | $-45.21M | $-85.93M | $-125.05M | $-103.31M | $-91.53M | $-68.88M |
| Investing cash flow | $-5.58M | $-7.01M | $-238.56M | $83.65M | $48.72M | $1.13M | — |
| Financing cash flow | $30.51M | $147.27M | $208.97M | $77.77M | $4.05M | $47.75M | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | $-90.41M | $56.99M | — | — | — |